Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of FYU-981 on QT/QTc Interval in Healthy Volunteers
NCT02515864Phase 2Completed
- Sponsor
- Fuji Yakuhin
- Start
- Aug 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dotinurad in hyperuricemia, gout, sponsored by Fuji Yakuhin. Started Aug 2015; status: completed.
02
Drugs
dotinurad
03
Conditions
hyperuricemiagout
Beyond the preview
Go deeper on NCT02515864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02515864.